Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Choosing points over cash back can be beneficial in specific situations. Understand when to make that switch for better rewards.
27,195 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A Seoul woman is accused of using an AI chatbot to help plan two fatal motel visits, sparking questions about AI safe...
A fiery address from Palantir’s CEO has ignited a broader debate on how AI firms partner with the Pentagon and how po...
The Real Brokerage is expanding its leadership with the appointment of Jason Cassity as Chief Growth Officer, a move ...
A push to name Kevin Warsh Fed Chair roils markets, sending XRP into a fresh swing as traders weigh policy, liquidity...
A major March storm grounded more than 1,800 flights across the United States, snarling spring break travel and forci...
Employer ghosting has escalated to a three-year peak, with more than half of job seekers reporting no response after ...
South Korea halts the 20% crypto tax on gains to 2027 after a surge of capital fleeing domestic markets, signaling a ...
Bitcoin harbors a tense battlefield near the $80,000 zone as aging coins hit the market and institutional buyers abso...
Venture firm Andreessen Horowitz and a growing mix of banks push a five-year horizon for autonomous AI agents to func...
Mungo Homes has named Ric Rojas president of its newly formed Mid-Atlantic region, a move designed to accelerate grow...
U.S. stocks edge lower as Iran tensions escalate, with the SPY and major indexes slipping while oil climbs and safe-h...